Odyssey Pharmaceuticals, Inc
Odyssey Pharmaceuticals, Inc. a leading pharmaceutical company, which is a subsidiary of PLIVA. It is the fastest-growing specialty pharmaceutical company in the research, development, and commercialization of innovative products to improve the quality of life.
Odyssey Pharmaceuticals, Inc. has focused on key therapeutic categories include urology, respiratory and central nervous systems. It has recently launched Sanctura, a prescription medicine that is used to treat overactive bladder. The company has more than 80 years of experience in the pharmaceuticals area, PLIVA d.d., headquartered in Zagreb, Croatia.
This parent company is a multinational corporation primarily focused on generic products, with operations across Central and Eastern Europe, Western Europe and the U.S. The parent organization is the largest central and eastern Europe-headquartered company in terms of sales. The most prominent discovery of the company is the blockbuster antibiotic azithromycin, sold under the trademarks of Zithromax, in the U.S. by Pfizer.
The team of the company works by sharing information and ideas more readily because the office layout was designed not only to be appealing but also to improve productivity. The staff of the leading organization Odyssey Pharmaceuticals, Inc. is enjoying amenities such as a flexible, high-tech training center, ample records storage, huge parking space, a fitness center, and a cafeteria.